Middle cerebral artery aneurysm case series

Thirty-four patients with complex MCA aneurysms were treated with bypass and aneurysm occlusion, five with surgical clipping or wrapping only, and one with aneurysm excision and primary re-anastomosis. Bypasses included STA-MCA, double-barrel STA-MCA, OA-MCA, and ECA-MCA. Following bypass, aneurysms were treated by surgical clipping, Hunterian ligation, trapping, or coil embolization.

Results: The average age at diagnosis was 46 years. 67% of the aneurysms were large and most involved the MCA bifurcation. Most bypasses performed were STA-MCA bypasses, 12 of which were double-barrel. There were two wound healing complications. All but two of the aneurysms treated demonstrated complete occlusion at the last follow up. There were three hemorrhagic complications, three graft thromboses, and four ischemic insults. Mean follow up is 73 months. 83% of patients reported stable or improved symptoms from presentation and 73% reported a functional status (GOS 4 or 5) at the latest available follow up.

Cerebral revascularization by bypass followed by aneurysm or parent artery occlusion is an effective treatment option for complex MCA aneurysms that cannot be safely treated by standard microsurgical or endovascular techniques. Double-barrel bypass consisting of two STA branches to two MCA branches yields adequate flow replacement in the majority of cases 1).


Jang et al. retrospectively reviewed cerebral aneurysm in the M2 and M3 segments of the MCA surgically treated between January 2015 and December 2022. The demographic data, aneurysm-related findings, type of surgical approach, surgical technique, and clinical outcomes of the enrolled patients were analyzed.

Sixteen distal MCA aneurysms were treated with microneurosurgery (incidence, 1.0%; female, 12; mean age, 58.1 years; ruptured, three). Twelve aneurysms were in the M2 segment (insular segment), two aneurysms at the M2-M3 junction, and two aneurysms in the M3 segment (opercular segment). Twelve aneurysms were saccular (average size, 4.9 mm; multiplicity, 50%; average aneurysms, 3.0; partially thrombosed, 1; sidewall aneurysm, 2). Three aneurysms were fusiform, of which two were ruptured. Of the ruptured aneurysms, one was a ruptured dissecting aneurysm. The trans-sylvian and trans-sulcal approaches were used in fourteen and two patients, respectively. Neck clipping, wrap clipping, and surgical trapping were performed in twelve, one, and one patient, respectively. Proximal occlusion was performed in one patient. Bypass technique was required in two patients (neck clipping and proximal occlusion). The modified Rankin Score was 6 in the two patients with ruptured aneurysms. The remaining patients did not show further neurological deterioration after microneurosurgery.

Distal MCA aneurysms had a high incidence of being diagnosed with multiple other aneurysms and were relatively non-saccular 2)


Patients who underwent FD stent treatment for MCA aneurysms with a resulting jailed cortical branch were included. Follow-up clinical, angiographic, and MRP examination findings were recorded. Different MRP parameters were measured in the MCA territory regarding the jailed branches.

Results: Eighteen patients treated endovascularly with flow diversion for a total of 20 MCA aneurysms were included. At angiographic follow-up, (median 35 months, range 7-95 months) complete occlusion was observed in 13 (65%) aneurysms and partial occlusion was observed in 6 (30%). The mean transit time (MTT) prolongation, MTT ratio, time-to-peak (TTP) prolongation, and TTP ratio were 1.34, 1.20, 1.18, and 1.06 s, respectively, when compared with the contralateral side in the MCA territory. MTT, TTP, and cerebral blood volume values of the patients showed statistically significant differences compared with the contralateral side (P<0.05).

Flow diversion treatment of complex bifurcation aneurysms can be effective and safe. MRP examination may reveal perfusion changes in the territory vascularized via a jailed branch, and these changes are rarely accompanied by clinical findings 3).

A study of Gou et al. from the Beijing Neurosurgical Institute, included 285 cases of middle cerebral artery aneurysm surgery with MEP monitoring. The effects of MEP changes on postoperative motor function were assessed, and the key time point for minimizing the incidence of postoperative motor dysfunction was found through receiver operating characteristic (ROC) curve analysis. Motor dysfunction was significantly associated with the occurrence of MEP changes, and patients with irreversible changes were more likely to suffer motor dysfunction than were those with reversible changes. The critical duration of MEP changes that minimized the risk of postoperative motor dysfunction was 8.5 min. This study revealed that MEP monitoring is an effective method for preventing ischemic brain injury during surgical treatment of MCA aneurysm and proposes a critical cutoff for the duration of MEP deterioration of 8.5 min for predicting postoperative motor dysfunction 4).

Esposito et al. from the Department of Neurosurgery, Clinical Neuroscience Center Zurich, report on a consecutive case-series of 50 patients who received clipping of 54 ruptured/unruptured middle cerebral artery aneurysm (MCA-aneurysms) by means of lateral supraorbital approach (LS) or minipterional craniotomy. The distance between MCA (M1)-origin and the aneurysmal neck is key to select the approach: LS was used for MCA-aneurysm located <15mm of the M1-origin and MP for MCA-aneurysms located ≥15mm of the M1-origin.

11 out of 50 patients presented with subarachnoid hemorrhage (10 ruptured MCA aneurysms). Overall, 59 aneurysms were successfully clipped (54 of the MCA). The mean distance between the M1-origin and the aneurysmal neck was 10.1-mm (range: 4-17mm) for patients treated by LS and 20-mm (range: 15-30mm) for MP. All but one MCA aneurysms were successfully treated. At last follow-up (mean 14 months), no reperfusion of the clipped aneurysms was observed.

The strategy for selecting the keyhole approach based on the depth of the aneurysm within the Sylvian fissure is efficient and safe. They suggest the use of LS approach when the aneurysm is located <15mm from the M1-origin and MP approach when the aneurysm is located ≥15mm from the M1-origin 5).

Eighteen intracranial aneurysms, including 13 unruptured and 5 ruptured aneurysms, were treated with LVIS Jr stent-assisted coil embolization.

A total of 18 stents were successfully delivered to the target aneurysms, and the technical success rate was 100%. There was complete occlusion in 8 (44.4%) of 18 cases, neck remnants in 7 (38.9%) cases, and partial occlusion in 3 (16.7%) cases. In-stent thrombosis occurred in 1 case, and the symptoms disappeared after transvenous tirofiban injection. The modified Rankin Scale score at discharge was 0 in 14 patients, 1 in 3 patients, and 2 in 1 patient.

The LVIS Jr stent provided excellent trackability and deliverability and is safe and effective for the treatment of wide-necked MCA aneurysms with tortuous and smaller parent vessels 6).

Clinical and radiological data of 103 patients interdisciplinary treated for unruptured MCA aneurysms over a 5-year period were analyzed in endovascular (n = 16) and microsurgical (n = 87) cohorts. Overall morbidity (Glasgow Outcome Score <5) after 12-month follow-up was 9 %. There was no significant difference between the two cohorts. Complete or “near complete” aneurysm occlusion was achieved in 97 and 75 % in the microsurgical, respective endovascular cohort. A “complex” aneurysm configuration had a significant impact on complete aneurysm occlusion in both cohorts, however, not on clinical outcome. Treatment of unruptured MCA aneurysms can be performed with a low risk of repair using both approaches. However, the risk for incomplete occlusion was higher for the endovascular approach in this series 7).

Five hundred forty-three patients with 631 MCA aneurysms were managed with a “clip first” policy, with 115 patients (21.2%) referred from the Neurointerventional Radiology service and none referred from the Neurosurgical service for endovascular management.

Two hundred eighty-two patients (51.9%) had ruptured aneurysms and 261 (48.1%) had unruptured aneurysms. MCA aneurysms were treated with clipping (88.6%), thrombectomy/clip reconstruction (6.2%), and bypass/aneurysm occlusion (3.3%). Complete aneurysm obliteration was achieved with 620 MCA aneurysms (98.3%); 89.7% of patients were improved or unchanged after therapy, with a mortality rate of 5.3% and a permanent morbidity rate of 4.6%. Good outcomes were observed in 92.0% of patients with unruptured and 70.2% with ruptured aneurysms. Worse outcomes were associated with rupture (P = .04), poor grade (P = .001), giant size (P = .03), and hemicraniectomy (P < .001).

At present, surgery should remain the treatment of choice for MCA aneurysms. Surgical morbidity was low, and poor outcomes were due to an inclusive policy that aggressively managed poor-grade patients and complex aneurysms. This experience sets a benchmark that endovascular results should match before considering endovascular therapy an alternative for MCA aneurysms 8).

Ogilvy et al., reviewed 65 middle cerebral aneurysms in 62 patients operated on over a 5-year interval where a choice of operative approach was made based on preoperative evaluation of available radiological studies.

The superior temporal gyrus was used when intraparenchymal hematoma was present in the temporal lobe or when the length of the middle cerebral artery trunk was long (average length 2.44 +/- 0.41 SE cm). This approach was used in 20 operations on 22 aneurysms. The sylvian fissure approach was used in cases where the middle cerebral artery main trunk was short (1.32 +/- 0.41 SE cm) or the direction of the aneurysm was favorable. This approach was used in 38 operations. In 4 operations (5 aneurysms) we combined the two approaches to remove clot, obtain adequate exposure, and secure control of the proximal MCA.

In most cases of MCA aneurysms the decision as to which surgical approach to use is made preoperatively depending on the presence of intraparenchymal clot, size of aneurysm, direction of aneurysm, and length of the proximal middle cerebral artery 9).


1)
Peeters SM, Colby GP, Kim WJ, Bae WI, Sparks H, Reitz K, Tateshima S, Jahan R, Szeder V, Nour M, Duckwiler GR, Vinuela F, Martin NA, Wang AC. Arterial Bypass in the Treatment of Complex Middle Cerebral Artery Aneurysms: Lessons Learned from 40 Patients. World Neurosurg. 2023 Oct 11:S1878-8750(23)01441-9. doi: 10.1016/j.wneu.2023.10.037. Epub ahead of print. PMID: 37832639.
2)
Jang T, Kim ST, Lee J, Lee WH, Lee KS, Pyo SY, Ko J, Lee H, Jeong YG. Microsurgical treatment of distal middle cerebral artery aneurysm: A single-center review. J Cerebrovasc Endovasc Neurosurg. 2023 Oct 4. doi: 10.7461/jcen.2023.E2023.06.005. Epub ahead of print. PMID: 37789514.
3)
Sakai C, Sakai N, Takayanagi A, Imamura H, Ohta T, Koyanagi M, Goto M, Fukumitsu R, Sunohara T, Fukui N, Matsumoto S, Akiyama T, Takano Y, Haruyama H, Go K, Kajiura S, Shigeyasu M, Asakura K, Horii R, Naramoto Y, Nishii R, Yamamoto Y, Teranishi K, Kawade S, Imahori T, Kaneko N, Tateshima S. First-in-human trial of Stabilizer device in neuroendovascular therapy. Heliyon. 2023 Mar 11;9(3):e14360. doi: 10.1016/j.heliyon.2023.e14360. PMID: 36950603; PMCID: PMC10025140.
4)
Guo D, Fan X, You H, Tao X, Qi L, Ling M, Li Z, Liu J, Qiao H. Prediction of postoperative motor deficits using intraoperative motor-evoked potentials in middle cerebral artery aneurysm. Neurosurg Rev. 2020 Jan 22. doi: 10.1007/s10143-020-01235-0. [Epub ahead of print] PubMed PMID: 31965363.
5)
Esposito G, Dias SF, Burkhardt JK, Fierstra J, Serra C, Bozinov O, Regli L. Selection strategy for optimal keyhole approaches for MCA aneurysms: lateral supraorbital versus minipterional craniotomy. World Neurosurg. 2018 Oct 13. pii: S1878-8750(18)32344-1. doi: 10.1016/j.wneu.2018.09.238. [Epub ahead of print] PubMed PMID: 30326308.
6)
Feng Z, Li Q, Zhao R, Zhang P, Chen L, Xu Y, Hong B, Zhao W, Liu J, Huang Q. Endovascular Treatment of Middle Cerebral Artery Aneurysm with the LVIS Junior Stent. J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1357-62. doi: 10.1016/j.jstrokecerebrovasdis.2015.02.016. Epub 2015 Apr 4. PubMed PMID: 25851343.
7)
Dammann P, Schoemberg T, Müller O, Özkan N, Schlamann M, Wanke I, Sandalcioglu IE, Forsting M, Sure U. Outcome for unruptured middle cerebral artery aneurysm treatment: surgical and endovascular approach in a single center. Neurosurg Rev. 2014 Oct;37(4):643-51. doi: 10.1007/s10143-014-0563-5. Epub 2014 Jul 9. PubMed PMID: 25005630.
8)
Rodríguez-Hernández A, Sughrue ME, Akhavan S, Habdank-Kolaczkowski J, Lawton MT. Current management of middle cerebral artery aneurysms: surgical results with a “clip first” policy. Neurosurgery. 2013 Mar;72(3):415-27. doi: 10.1227/NEU.0b013e3182804aa2. PubMed PMID: 23208060.
9)
Ogilvy CS, Crowell RM, Heros RC. Surgical management of middle cerebral artery aneurysms: experience with transsylvian and superior temporal gyrus approaches. Surg Neurol. 1995 Jan;43(1):15-22; discussion 22-4. PubMed PMID: 7701417.
  • middle_cerebral_artery_aneurysm_case_series.txt
  • Last modified: 2024/06/07 02:55
  • by 127.0.0.1